Jennison Associates
MANE

Jennison Associates’s Veradermics Inc MANE Stock Holding History

Jennison Associates’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92M Buy
748,678
+606,897
+428% +$56.9M 0.06% 175
2026
Q1 		$8.95M Buy
+141,781
New +$7.15M 0.01% 392

Other funds holding MANE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Jennison Associates's MANE Position: Q2 2026 in Review

Jennison Associates increased its Veradermics Inc (MANE) stake by 428% in Q2 2026, buying an estimated $56.9M and bringing the position to 748,678 shares worth $92M. The position accounts for 0.06% of the portfolio, ranked #175.

Jennison Associates first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 46 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Jennison Associates held 748,678 shares of Veradermics Inc worth $92M as of Q2 2026.
  • Jennison Associates bought 606,897 Veradermics Inc shares in Q2 2026, an estimated $56.9M.
  • Veradermics Inc made up 0.06% of Jennison Associates's portfolio in Q2 2026, its #175 holding.
  • Jennison Associates first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 46 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.